Cargando…
REV1 Inhibition Enhances Radioresistance and Autophagy
SIMPLE SUMMARY: Cancer resistance to therapy continues to be the biggest challenge in treating patients. Targeting the mutagenic translesion synthesis (TLS) polymerase REV1 was previously shown to sensitize cancer cells to chemotherapy. In this study, we tested the ability of REV1 inhibitors to radi...
Autores principales: | Ikeh, Kanayo E., Lamkin, Erica N., Crompton, Andrew, Deutsch, Jamie, Fisher, Kira J., Gray, Mark, Argyle, David J., Lim, Won Y., Korzhnev, Dmitry M., Hadden, M. Kyle, Hong, Jiyong, Zhou, Pei, Chatterjee, Nimrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582445/ https://www.ncbi.nlm.nih.gov/pubmed/34771454 http://dx.doi.org/10.3390/cancers13215290 |
Ejemplares similares
-
Evolution of Rev7 interactions in eukaryotic TLS DNA polymerase Polζ
por: McPherson, Kerry Silva, et al.
Publicado: (2022) -
SARS-CoV-2 triggers DNA damage response in Vero E6 cells
por: Victor, Joshua, et al.
Publicado: (2021) -
SARS-CoV-2 hijacks host cell genome instability pathways
por: Victor, Joshua, et al.
Publicado: (2022) -
REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2
por: Gu, Cheng, et al.
Publicado: (2019) -
Exosomes Derived from Radioresistant Breast Cancer Cells Promote Therapeutic Resistance in Naïve Recipient Cells
por: Payton, Chantell, et al.
Publicado: (2021)